CNB
MRNA icon

Czech National Bank’s Moderna MRNA Stock Holding History

Czech National Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Buy
100,517
+5,808
+6% +$300K 0.04% 349
2026
Q1 		$4.81M Buy
94,709
+3,025
+3% +$141K 0.03% 399
2025
Q4 		$2.7M Buy
91,684
+3,736
+4% +$102K 0.02% 470
2025
Q3 		$2.27M Buy
87,948
+4,759
+6% +$133K 0.02% 477
2025
Q2 		$2.3M Buy
83,189
+5,409
+7% +$142K 0.02% 470
2025
Q1 		$2.21M Buy
77,780
+4,356
+6% +$155K 0.02% 469
2024
Q4 		$3.05M Buy
73,424
+4,526
+7% +$216K 0.03% 431
2024
Q3 		$4.6M Buy
68,898
+5,362
+8% +$492K 0.05% 336
2024
Q2 		$7.54M Buy
63,536
+5,170
+9% +$654K 0.09% 210
2024
Q1 		$6.22M Buy
58,366
+268
+0.5% +$27K 0.08% 244
2023
Q4 		$5.78M Buy
58,098
+226
+0.4% +$19K 0.08% 250
2023
Q3 		$5.98M Buy
57,872
+19,062
+49% +$2.13M 0.1% 220
2023
Q2 		$4.72M Sell
38,810
-140
-0.4% -$18.7K 0.11% 193
2023
Q1 		$5.98M Buy
38,950
+277
+0.7% +$45.7K 0.15% 140
2022
Q4 		$6.95M Sell
38,673
-416
-1% -$68K 0.18% 120
2022
Q3 		$4.62M Buy
+39,089
New +$5.93M 0.13% 161

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Czech National Bank's MRNA Position: Q2 2026 in Review

Czech National Bank increased its Moderna (MRNA) stake by 6.1% in Q2 2026, buying an estimated $300K and bringing the position to 100,517 shares worth $7.04M. The position accounts for 0.04% of the portfolio, ranked #349.

Czech National Bank first reported a position in MRNA in Q3 2022 and has held it in 16 quarters since. The position peaked at $7.54M in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Czech National Bank held 100,517 shares of Moderna worth $7.04M as of Q2 2026.
  • Czech National Bank bought 5,808 Moderna shares in Q2 2026, an estimated $300K.
  • Moderna made up 0.04% of Czech National Bank's portfolio in Q2 2026, its #349 holding.
  • Czech National Bank first reported a position in Moderna in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Moderna position peaked at $7.54M in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.